搜索
产品
社区
市场
新闻
经纪商
更多
CN
开始
$ABBV AbbVie forms a breakout set up pattern.
做多
AbbVie Inc.
(
NYSE:ABBV
)
IvanStruk
NYSE:ABBV
AbbVie Inc.
Trend Analysis
Cup And Handle
2
0
trendanalysis
cupandhandle
AbbVie, although overvalued, and with little revenue diversification still has the most profitable drug on the US pharmaceutical market, Humira, with a longstanding patent. ABBV still have plenty of momentum to beat it's median price target of $95.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在
使用条款
阅读更多信息。